STOCK Tg(Lck-AVEN)1Zrng/Ieg
| Status | Available to order |
| EMMA ID | EM:01916 |
| Citation information | RRID:IMSR_EM:01916 Research Resource Identifiers (RRID) are persistent unique ID numbers assigned to help researchers cite key resources (e.g. antibodies, model organisms and software projects) in the biomedical literature to improve transparency and reproducibility in research. See https://www.rrids.org/ for more information. |
| International strain name | STOCK Tg(Lck-AVEN)1Zrng/Ieg |
| Alternative name | lck Aven |
| Strain type | Transgenic Strains |
| Allele/Transgene symbol | Tg(Lck-AVEN)1Zrng |
| Gene/Transgene symbol | Tg(Lck-AVEN)1Zrng |
Information from provider
| Provider | Martin Zoernig |
| Provider affiliation | Chemotherapeutisches Forschungsinstitut Georg-Speyer-Haus, University of Frankfurt |
| Genetic information | Human AVEN cDNA was cloned and placed under control of the Lck promoter into the p1017 vector to achieve T cell-specific expression of the transgene. |
| Phenotypic information | The mice appear normal. |
| Breeding history | The transgenic mice were backcrossed for 4 generations to the C57BL/6 background. |
| References |
|
Information from EMMA
| Archiving centre | Helmholtz Zentrum Muenchen - German Research Center for Environmental Health (GmbH), Oberschleißheim, Germany |
Literature references
- Aven, a novel inhibitor of caspase activation, binds Bcl-xL and Apaf-1.;Chau B N, Cheng E H, Kerr D A, Hardwick J M, ;2000;Molecular cell;6;31-40; 10949025
- Involvement of p21ras distinguishes positive and negative selection in thymocytes.;Swan K A, Alberola-Ila J, Gross J A, Appleby M W, Forbush K A, Thomas J F, Perlmutter R M, ;1995;The EMBO journal;14;276-85; 7835338
Information on how we integrate external resources can be found here
INFRAFRONTIER® and European Mouse Mutant Archive - EMMA® are registered trademarks at the European Union Intellectual Property Office (EUIPO).
